Who owns INOZYME PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Inozyme Pharma stock

Who bought or sold INOZYME PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Morgan Stanley 125k $499k 100% Jun 2025
 View chart

Who sold out of Inozyme Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Beryl Capital Management Jun 2025 6.3M $25M
Pivotal bioVenture Partners Investment Advisor Jun 2025 4.5M $18M
Glazer Capital Jun 2025 4.3M $17M
Sofinnova Ventures Jun 2025 4.3M $17M
Oddo Bhf Asset Management Sas Jun 2025 3.2M $13M
Trium Capital Jun 2025 3.2M $13M
BlackRock Jun 2025 2.7M $11M
Vanguard Group Jun 2025 2.5M $10M
NEA Management Company Jun 2025 2.4M $9.8M
Alpine Associates Management Jun 2025 2.2M $8.8M
Affinity Asset Advisors Jun 2025 1.7M $7.0M
Gabelli Funds Jun 2025 1.5M $5.8M
Gardner Lewis Asset Management Jun 2025 1.3M $5.0M
Geode Capital Management Jun 2025 1.2M $4.9M
OMERS Administration Corporation Jun 2025 1.1M $4.5M
Man Group Jun 2025 670k $2.7M
Knott David M Jr Jun 2025 666k $2.7M
Gabelli Securities Jun 2025 617k $2.5M
Woodline Partners Jun 2025 535k $2.1M
Millennium Management Jun 2025 482k $1.9M
Renaissance Technologies Jun 2025 471k $1.9M
Sanofi Jun 2025 443k $1.8M
Skandinaviska Enskilda Banken AB Jun 2025 377k $1.5M
Oxford Asset Management Jun 2025 362k $1.4M
State Street Corporation Jun 2025 332k $1.3M
Susquehanna Portfolio Strategies Jun 2025 261k $1.0M
Susquehanna International Jun 2025 258k $1.0M
Goldman Sachs Group Mar 2025 234k $213k
Groupe la Francaise Jun 2025 224k $895k
Water Island Capital Jun 2025 202k $807k
Citadel Advisors Jun 2025 164k $656k
Credit Industriel Et Commercial Jun 2025 149k $597k
Northern Trust Jun 2025 139k $556k